These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31839873)

  • 1. Using Adaptive Designs to Avoid Selecting the Wrong Arms in Multiarm Comparative Effectiveness Trials.
    Gajewski BJ; Statland J; Barohn R
    Stat Biopharm Res; 2019; 11(4):375-386. PubMed ID: 31839873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian adaptive designs for multi-arm trials: an orthopaedic case study.
    Ryan EG; Lamb SE; Williamson E; Gates S
    Trials; 2020 Jan; 21(1):83. PubMed ID: 31937341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simulation study of outcome adaptive randomization in multi-arm clinical trials.
    Wathen JK; Thall PF
    Clin Trials; 2017 Oct; 14(5):432-440. PubMed ID: 28982263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness Research using Bayesian Adaptive Designs for Rare Diseases: Response Adaptive Randomization Reusing Participants.
    Tang F; Gajewski BJ
    Stat Biopharm Res; 2023; 15(1):154-163. PubMed ID: 36875290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulation study for evaluating the performance of response-adaptive randomization.
    Du Y; Wang X; Jack Lee J
    Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.
    Brown AR; Gajewski BJ; Aaronson LS; Mudaranthakam DP; Hunt SL; Berry SM; Quintana M; Pasnoor M; Dimachkie MM; Jawdat O; Herbelin L; Barohn RJ
    Trials; 2016 Aug; 17(1):428. PubMed ID: 27577191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of response adaptive randomization features in multiarm clinical trials with control.
    Viele K; Saville BR; McGlothlin A; Broglio K
    Pharm Stat; 2020 Sep; 19(5):602-612. PubMed ID: 32198968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of statistical features of a Bayesian two-armed responsive adaptive randomization trial with post hoc analysis of time trend drift.
    Shergina E; Richter KP; Zhang C; Mussulman L; Nazir N; Gajewski BJ
    J Biopharm Stat; 2024 Jun; ():1-15. PubMed ID: 38847351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
    Lin J; Bunn V
    Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.
    Meinzer C; Martin R; Suarez JI
    Trials; 2017 Sep; 18(1):420. PubMed ID: 28886745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian Adaptive Randomization and Trial Monitoring with Predictive Probability for Time-to-event Endpoint.
    Yin G; Chen N; Lee JJ
    Stat Biosci; 2018 Aug; 10(2):420-438. PubMed ID: 30559900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPN.
    Brown AR; Gajewski BJ; Mudaranthakam DP; Pasnoor M; Dimachkie MM; Jawdat O; Herbelin L; Mayo MS; Barohn RJ
    Contemp Clin Trials Commun; 2023 Dec; 36():101220. PubMed ID: 37965484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preference-adaptive randomization in comparative effectiveness studies.
    French B; Small DS; Novak J; Saulsgiver KA; Harhay MO; Asch DA; Volpp KG; Halpern SD
    Trials; 2015 Mar; 16():99. PubMed ID: 25887045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian response-adaptive trial in tuberculosis: The endTB trial.
    Cellamare M; Ventz S; Baudin E; Mitnick CD; Trippa L
    Clin Trials; 2017 Feb; 14(1):17-28. PubMed ID: 27559021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical response adaptive block randomization (RABR) design with analytic type I error protection.
    Zhan T; Cui L; Geng Z; Zhang L; Gu Y; Chan ISF
    Stat Med; 2021 Oct; 40(23):4947-4960. PubMed ID: 34111902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.
    Thall P; Fox P; Wathen J
    Ann Oncol; 2015 Aug; 26(8):1621-8. PubMed ID: 25979922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian-adaptive decision-theoretic approach can reduce the sample sizes for multiarm exercise oncology trials.
    Buffart LM; Bassi A; Stuiver MM; Aaronson NK; Sonke GS; Berkhof J; van de Ven PM
    J Clin Epidemiol; 2023 Jul; 159():190-198. PubMed ID: 37245703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When to keep it simple - adaptive designs are not always useful.
    Wason JMS; Brocklehurst P; Yap C
    BMC Med; 2019 Aug; 17(1):152. PubMed ID: 31370839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of methodological considerations regarding adaptive stopping, arm dropping, and randomization in clinical trials.
    Granholm A; Kaas-Hansen BS; Lange T; Schjørring OL; Andersen LW; Perner A; Jensen AKG; Møller MH
    J Clin Epidemiol; 2023 Jan; 153():45-54. PubMed ID: 36400262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.